Geode Capital Management
JUNS

Geode Capital Management’s Jupiter Neurosciences JUNS Stock Holding History

Geode Capital Management’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4K Sell
2,082
-741
-26% -$17.5K ﹤0.01% 4306
2026
Q1 		$79.6K Buy
2,823
+1,054
+60% +$48.6K ﹤0.01% 4184
2025
Q4 		$135K Buy
1,769
+385
+28% +$38.4K ﹤0.01% 4024
2025
Q3 		$183K Buy
+1,384
New +$157K ﹤0.01% 3952

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59B AUM 51.04% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

Geode Capital Management's JUNS Position: Q2 2026 in Review

Geode Capital Management reduced its Jupiter Neurosciences (JUNS) stake by 26% in Q2 2026, selling an estimated $17.5K and leaving 2,082 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4306.

Geode Capital Management first reported a position in JUNS in Q3 2025 and has held it in 4 quarters since. The position peaked at $183K in Q3 2025. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • Geode Capital Management held 2,082 shares of Jupiter Neurosciences worth $33.4K as of Q2 2026.
  • Geode Capital Management sold 741 Jupiter Neurosciences shares in Q2 2026, an estimated $17.5K.
  • Jupiter Neurosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4306 holding.
  • Geode Capital Management first reported a position in Jupiter Neurosciences in Q3 2025 and has held it in 4 quarters since.
  • Geode Capital Management's Jupiter Neurosciences position peaked at $183K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.